CINECA IRIS Institutional Research Information System

GASCO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.622
EU - Europa 6.958
AS - Asia 2.743
AF - Africa 74
OC - Oceania 37
SA - Sud America 37
Continente sconosciuto - Info sul continente non disponibili 17
Totale 19.488
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.463
CN - Cina 1.760
DE - Germania 1.052
IT - Italia 955
SE - Svezia 951
IE - Irlanda 856
UA - Ucraina 671
FR - Francia 539
GB - Regno Unito 468
FI - Finlandia 463
KR - Corea 357
AT - Austria 290
VN - Vietnam 265
PL - Polonia 260
CA - Canada 150
DK - Danimarca 147
IN - India 111
RU - Federazione Russa 72
JP - Giappone 65
BE - Belgio 61
SN - Senegal 52
TW - Taiwan 49
GR - Grecia 41
NL - Olanda 39
ES - Italia 31
SG - Singapore 28
AU - Australia 27
BR - Brasile 21
TR - Turchia 21
EU - Europa 17
HK - Hong Kong 15
CH - Svizzera 14
IR - Iran 14
UZ - Uzbekistan 14
RO - Romania 10
EG - Egitto 9
MX - Messico 9
NZ - Nuova Zelanda 9
BG - Bulgaria 8
JO - Giordania 8
NO - Norvegia 7
MU - Mauritius 6
CL - Cile 5
HR - Croazia 5
HU - Ungheria 5
TH - Thailandia 5
ID - Indonesia 4
MY - Malesia 4
PK - Pakistan 4
ZA - Sudafrica 4
CO - Colombia 3
CY - Cipro 3
CZ - Repubblica Ceca 3
IL - Israele 3
IQ - Iraq 3
PE - Perù 3
PT - Portogallo 3
AM - Armenia 2
EC - Ecuador 2
PH - Filippine 2
QA - Qatar 2
SC - Seychelles 2
SI - Slovenia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
IM - Isola di Man 1
LT - Lituania 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
PW - Palau 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 19.488
Salva come PNG Salva come JPEG
Città #
Chandler 1.347
Ann Arbor 1.120
Beijing 1.080
Dublin 852
Fairfield 677
Ashburn 458
Jacksonville 435
Houston 367
Dearborn 363
Woodbridge 363
Villeurbanne 305
Wilmington 302
Seattle 297
Vienna 285
Princeton 278
Torino 264
Medford 255
Nyköping 255
Warsaw 253
Dong Ket 223
Cambridge 216
Pisa 190
Frankfurt am Main 137
Munich 106
Fremont 101
Redwood City 99
Milan 92
Boston 86
Shanghai 68
Boardman 63
Brussels 58
Nanjing 58
Guangzhou 53
Hangzhou 52
Verona 51
Ottawa 45
Toronto 45
Taipei 42
Falls Church 41
Norwalk 41
Helsinki 40
San Diego 37
Shenyang 35
Lachine 33
Hefei 31
Zhengzhou 30
Düsseldorf 28
Washington 28
New York 27
Pune 25
Jinan 24
Kharkiv 20
Kunming 20
Monmouth Junction 20
Philadelphia 19
Tokyo 19
Phoenix 18
Turin 18
Wuhan 18
Nürnberg 17
Chengdu 16
Nanchang 16
Siena 16
Toledo 15
Silver Spring 14
Hebei 13
Nuremberg 13
Rome 13
Lansing 12
Los Angeles 12
Nottingham 12
Changsha 11
Copenhagen 11
Leinì 11
Mountain View 11
Xian 11
Bologna 10
Des Moines 9
Fuzhou 9
Tianjin 9
Ardabil 8
Buffalo 8
Dallas 8
London 8
Tappahannock 8
West Jordan 8
Cardiff 7
Catania 7
Florence 7
Leawood 7
Dresden 6
Latina 6
San Mateo 6
Upper Marlboro 6
Amman 5
Berlin 5
Brisbane 5
Cairo 5
Granada 5
Harbin 5
Totale 12.304
Salva come PNG Salva come JPEG
Nome #
Quinone based nitric oxide donating compounds 485
1,2,5-Oxadiazole analogues of leflunomide and related compounds 428
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance 398
1,1-Dinitroethyl substituted furoxans : a new class of vasodilators and inhibitors of platelet aggregation 341
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells 298
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance 280
New furoxan derivatives for the treatment of ocular hypertension 264
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts 264
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors. 260
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease 254
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 246
Doxorubicin-antioxidant multitarget drugs 240
New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold 234
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity 224
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile 210
Edaravone derivatives containing NO-donor functions 204
4-Hydroxy-1,2,5-oxadiazol-3-yl Moiety as Bioisoster of the Carboxy Function. Synthesis, Ionization Constants, and Molecular Pharmacological Characterization at Ionotropic Glutamate Receptors of Compounds Related to Glutamate and Its Homologues 188
1,4-Dihydropyridines containing R-NNO-azoxy moieties 186
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins 186
A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery 183
Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein 171
New nitric oxide or hydrogen sulfide releasing aspirins 164
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs 163
Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria 156
A Nonmetal-Containing Nitric Oxide Donor Activated with Single-Photon Green Light 155
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants 154
Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues. 148
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury 146
Combination of PDT and NOPDT with a tailored BODIPY derivative 146
Light-Tunable Generation of Singlet Oxygen and Nitric Oxide with a Bichromophoric Molecular Hybrid: a Bimodal Approach to Killing Cancer Cells 141
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization 139
Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth 139
4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation. 134
Nitrooxymethyl-Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization 133
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties 131
Synthesis and biological evaluation of the first example of NO-donor histone deacetylase inhibitor 126
A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells 126
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans 126
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs) 125
Searching for new NO-donor Aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid 124
Activation of endothelial guanylate cyclase inhibits cellular reactivity. 123
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid (ASA) Prodrugs 123
Multitarget Drugs: Synthesis and Preliminary Pharmacological Characterization of Zileuton Analogues Endowed with Dual 5-LO Inhibitor and NO-Dependent Activities 119
A new class of NO-donor H3-Antagonists 117
Amphiphilic NO-Donor Antioxidants 117
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae 117
Composti ibridi per il trattamento della malaria cerebrale 116
Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents 115
NO-Donor Melatonin Derivatives: Synthesis And In Vitro Pharmacological Characterization 115
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties 114
Multitarget Drugs: Focus on the NO-donor hybrid drugs 114
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity 112
New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni 111
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile 108
Carnosine analogues containing Phenol substructures 106
NO-donors: focus on furoxan derivatives 105
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light 105
Use of Nitric Oxide Releasing Furoxan System in the Design of "Hybrids": Substitution of Furoxan Moieties for the Furan Ring in Prazosin 104
SAR STUDIES ON H2 ANTAGONISTS CONTAINING ALKYLAMINO SUBSTITUTED 1,2,5-THIADIAZOLE 1-OXIDE MOIETIES 102
Inhibition of Human Placenta Glutathione Transferase P1-1 by the Antibiotic Calvatic Acid and its Diazocyanide Analogue: Evidence for Multiple Catalytic Intermediates 101
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties 101
New potential uroselective NO-donor a1-antagonists 97
Activité contre les Microorganismes de dex Pyrazolyldiazène carbonitriles Oxyde-2 97
Characterization of a new compound, S35b, as a guanylate cyclase activator in human platelets. 96
A novel hybrid aspirin-NO releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages 96
A new class of ibuprofen derivatives with reduced gastrotoxicity 95
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor 95
Synthesis and pharmacological characterisation of new H2-antagonists containing NO-donor moieties, endowed with mixed antisecretory and gastroprotective activities. 95
[3-(1H-Imidazol-4-yl)propyl)guanidines Containing Furoxan Moieties: A New Class of H3-Antagonists Endowed with NO-Donor Properties 94
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma 94
ALPHA(1)-ADRENOCEPTOR BLOCKING ACTIVITY OF SOME RING-OPEN ANALOGS OF PRAZOSIN 93
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives 93
Synthesis and Structure of a Trimer of the Furoxan System with High Vasodilator and Platelet Antiaggregatory Activity 93
A new furoxan NO-donor rabeprazole derivative and related compounds 91
Anti-Helicobacter pylori Agents Endowed with H2-antagonist Properties 89
Activity of calvatic acid and its analogs against Helicobacter pylori 89
Characterisation of Furoxancarbonitriles as a New Class of Vasodilators 89
6-Cyclohexylmethoxy-5-(cyano-NNO-azoxy)pyrimidine-4-amine: A new scaffold endowed with potent CDK2 inhibitory activity 88
DNA-targeted NO release photoregulated by green light 88
A Directed Synthesis of Alkyl, Aryl, and Heteroaryl-ONN-azoxycyanides 87
Unsymmetrically Substituted Furoxans. VII. A 13C NMR Study of a Series of Isomeric Pairs of Furoxans and the Structure of the two Isomeric Chlorophenyl furoxans 87
Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives 86
A multitarget approach to optimize the safety profile of coxibs: lumiracoxib derivatives with dual cyclooxygenase-2 inhibitor-thromboxane A2 receptor antagonist activity 83
13C and 15N Solution and Solid-state Nuclear Magnetic Resonance Study of the Intermolecular interactions in the 1:1 Trimethoprim:Sulphamethoxazole Complex 83
Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin-Like Molecules that Covalently Inactivate Cyclooxygenase-1 83
Furoxan derivatives as NO-donors 82
A NEW CLASS OF FUROXAN DERIVATIVES AS NO DONORS - MECHANISM OF ACTION AND BIOLOGICAL-ACTIVITY 82
Oximation of Acetyl(hydroxyimino)acetone: Nuclear Magnetic Resonance Spectroscopic, Chemical, and X-Ray Crystallographic Studies of the Reaction Products 82
S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells. 81
Studies on New Basic NO-Donor 1,4-Dihydropyridines 80
Novel Organic Nitrate Esters 80
Searching for Balanced Hybrid NO-Donor 1,4-Dihydropyridines with Basic Properties 80
CC1000: a new cardioprotective agent against ischemia/reperfusion injuries 80
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan 80
Pharmacochemistry of the Furoxan Ring : Recent Developments 79
Use of the furoxan (1,2,5-oxadiazole 2-oxide) system in the design of new NO-donor antioxidant hybrids 78
WATER SOLUBLE FUROXAN DERIVATIVES AS NO PRODRUGS 77
Synthesis and antimalarial activities of some furoxan sulfones and related furazans 77
Synthesis, physico-chemical characterization, andbiological activities of new carnosine derivatives stablein human serum as potential neuroprotective agents 77
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors 77
Totale 13.938
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.928
article - articoli 0
book - libri 0
conference - conferenze 6.906
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.834
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019728 0 0 0 0 0 0 0 0 0 0 518 210
2019/20203.332 106 99 230 354 254 497 410 193 388 367 237 197
2020/20212.297 211 159 167 107 175 141 154 119 345 193 139 387
2021/20223.161 153 131 175 248 231 68 292 212 103 307 648 593
2022/20233.662 446 364 105 380 280 882 400 207 321 83 119 75
2023/20241.098 171 223 102 75 115 194 51 56 17 84 10 0
Totale 20.202